维普期刊资源整合服务平台（V6.5）

88篇 您的检索式：作者名="Tan AR"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Small cell variant of anaplastic large cell lymphoma with positive ilmnunoreactivity for CD99显示文摘	Shiran MS Tan GC Sabariah AR	2008	Med J Malaysia2008，63，2：	1
2	Prospect for antisense techniques显示文摘	Zheng JG Tan TZ Kuang AR	1999	J Biomed Eng China1999，16，：	1
3	Review of Flavopirid~l, a cyclin - de- pendent kinase inhibitor, as breast cancer therapy显示文摘	Tan AR Swain SM	2002	Seminars in oncology2002，29，3：	1
4	Evaluation of biologic end points and pharmacokineties in patients with metastatic breast cancer after treatment with erolotinib, an epidermal growth factor receptor tyrosine kinase inhibitor 显示文摘	Tan AR Yang X Hewitt SM	2004	J Clin Oncol2004，22，：	1
5	Neuroanatomical correlates of phonolog-ical processing of Chinese characters and alphabetic words : a meta-a- nalysis 显示文摘	Tan LH Laird AR Li K	2005	Hum Brain Mapp2005，25，1：	1
6	Therapeutic strategies for triple-negative breast cancer显示文摘	Tan AR Swain SM	2008	Cancer J2008，14，6：	1
7	Abdominal migraine and treatment with intravenous valproic acid 显示文摘	Tan V Sahami AR Peebles R	2006	Psychosomatics2006，47，4：	1
8	Saxagliptin added to asubmaximal dose of sulphonylurea improves glycaemic control com-pared with uptitration of sulphonylurea in patients with type 2 dia-betes:a randomised controlled trial显示文摘	Chacra AR Tan GH Apanovitch A	2009	Clin Pract2009，63，9：	1
9	Safety and effi- cacy of saxagliptin in combination with submaximal sulphony- lurea versus up-titrated sulphonylurea over 76 weeks显示文摘	Chacra AR Tan GH Ravichandran S	2011	Ia- betes and Vascular Disease Research2011，8，2：	1
10	Therapeutic strategies for triple-negative breast cancer 显示文摘	Tan AR Swain SM	2008	Cancer J2008，14，6：	1
11	An immunohistochemical study of toll-like receptors 2 and 4 in placenta with and without infection显示文摘	Hayati AR Mohamed AE Tan GC	2010	Malays J Pathol2010，32，1：	1
12	Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial 显示文摘	Chacra AR Tan GH Apanovitch A	2009	Int J Clin Pract2009，63，9：	1
13	Review of Flavopiridol, a cyclindependent kinase inhibitor, as breast cancer therapy显示文摘	Tan AR Swain SM	2002	Semin Oncol2002，29，3：	1
14	Molecular pathogenesis of progression and recurrence in breast phyllodes tumors显示文摘	Jara-Lazaro AR Tan PH	2009	Am J Transl Res2009，1，1：	1
15	Therapeutic strategies for triple-negative breast cancer显示文摘	Tan AR Swain SM		0，，06：	1
16	Therapeutic strategies for triple-negative breast cancer显示文摘	Tan AR Swain SM	2008	Cancer J2008，14，6：	1
17	Saxagliptinadded to a submaximal dose of sulphonylurea improvesglycaemic control compared with uptitration of sulphony-lurea in patients with type 2 diabetes : A randomised con-trolled trial 显示文摘	Chacra AR Tan GH Apanovitch A	2009	International Journal of Clinical Practice2009，63，9：	1
18	Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes:a randomised controlled trial显示文摘	Chacra AR Tan GH Apanovitch A		0，，09：	1
19	Molecular pathogenesis of progression and recurrence in breast phyllodes tumors 显示文摘	Jara-Lazaro AR Tan PH	2009	Am J Transl Res2009，1，1：	1
20	Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor 显示文摘	Tan AR Yang X Hewitt SM	2004	J Clin Oncol2004，22，15：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示